To identify the battery of genes responsive to the different treatments, RNA-seq was performed using RNA extracted from 13 tumor samples representing the 4 study groups: 2 control tumor samples, 4 IGF1R inhibitor-treated tumor samples, 3 anti-PD-1-treated tumor samples and 4 anti-PD-1/IGF1R-treated tumor samples. Here, PDCD1 is linked to neoplasm.